Rodent pancreatic islet biology in health and disease
啮齿动物胰岛生物学在健康和疾病中的作用
基本信息
- 批准号:8157989
- 负责人:
- 金额:$ 19.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
During 2009, we further developed multicolor flow cytometry and quantitative gene expression systems to characterize endocrine cell number and function in both healthy mice and mice developing or with recent autoimmune diabetes. Specific observations:
1. Using beta cell DNA content analysis (validated using standard BrdU incorporation techniques), we found increased (at least 5-6 fold) beta cell proliferation at diabetes onset compared to beta cells from healthy mice. The observed beta cell proliferation at diabetes onset is consistent with results from severe insulin-resistance mouse models which typically develop marked beta cell hyperplasia over time. We tested whether the beta cell proliferation in autoimmune diabetes is caused by hyperglycemia or the islet inflammation, with data clearly suggesting the former. For instance, proliferating cell frequency is markedly lower in prediabetic mice compared to recently diabetic animals, even though prediabetic mouse islets are severely infiltrated and substantial islet injury has occurred. A manuscript reporting these observations was published this year.
2. Using flow cytometry and fluorescence immunohistochemistry, we have determined the frequency of mouse pancreatic beta cells relative to alpha- or delta-cells during diabetes development. In addition to the expected beta cell depletion, we observed an equally severe loss of alpha and delta cells. This other-than-beta-cell depletion from islets was much more prevalent in larger islets compared with small, sub-islet-sized endocrine cell clusters. Also, during autoimmune beta cell destruction, islet alpha- and delta-cell proliferation rates did not increase, unlike beta cells. Our data suggest that the distribution of endocrine cells between larger islets and small endocrine cell clusters changes as autoimmune diabetes develops, and may play a role in the paradoxical hormonal responses observed in diabetic subjects. For instance, while patients with diabetes typically display higher than normal circulating glucagon levels, the normal glucagon response to hypoglycemia is typically blunted. A manuscript reporting these observations was published this year.
3. We have developed a technique that can quickly and with some precision measure total pancreatic endocrine cell numbers. Using current techniques, a number of agents have been reported to increase "islet cell mass", but such assessments are typically drawn using laborious and imprecise immunohistological techniques. With the flow cytometric systems we are developing, we can track both the decline in beta cell numbers involved in the processes leading to autoimmune diabetes, and the increase in beta cell numbers believed to occur in insulin resistant states or following treatment with certain islet growth factors (e.g. glucagon-like peptide 1 receptor agonists). Further, we have identified techniques for measuring the gene transcripts within individual islet cell subsets, and a manuscript reporting these observations is not "in press."
在2009年,我们进一步开发了多色流式细胞术和定量基因表达系统,以表征健康小鼠和发展或患有自身免疫性糖尿病的小鼠的内分泌细胞数量和功能。具体的观察:
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes.
- DOI:10.2337/db08-0616
- 发表时间:2009-05
- 期刊:
- 影响因子:7.7
- 作者:Pechhold K;Zhu X;Harrison VS;Lee J;Chakrabarty S;Koczwara K;Gavrilova O;Harlan DM
- 通讯作者:Harlan DM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Harlan其他文献
David Harlan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Harlan', 18)}}的其他基金
Secondary Prevention Trials For Recently Diagnosed T1DM
最近诊断的 T1DM 的二级预防试验
- 批准号:
6546668 - 财政年份:
- 资助金额:
$ 19.07万 - 项目类别:
Immunological mechanisms underlying T1DM pathogenesis
T1DM 发病机制的免疫学机制
- 批准号:
6421543 - 财政年份:
- 资助金额:
$ 19.07万 - 项目类别:
Immunological Mechanisms Underlying T1dm Pathogenesis
T1dm 发病机制的免疫学机制
- 批准号:
6821154 - 财政年份:
- 资助金额:
$ 19.07万 - 项目类别:
03-DK-0245 (Effect of AC2993 (synthetic exendin-4) on pancreatic islet function)
03-DK-0245(AC2993(合成exendin-4)对胰岛功能的影响)
- 批准号:
7593679 - 财政年份:
- 资助金额:
$ 19.07万 - 项目类别:
Immunological Mechanisms Underlying T1dm Pathogenesis
T1dm 发病机制的免疫学机制
- 批准号:
7593759 - 财政年份:
- 资助金额:
$ 19.07万 - 项目类别:
Assessing a PET-based technique for characterizing beta cell mass in vivo
评估基于 PET 的体内 β 细胞质量表征技术
- 批准号:
7593683 - 财政年份:
- 资助金额:
$ 19.07万 - 项目类别:
03-DK-0245 (Effect of AC2993 (synthetic exendin-4) on pancreatic islet function)
03-DK-0245(AC2993(合成exendin-4)对胰岛功能的影响)
- 批准号:
7734207 - 财政年份:
- 资助金额:
$ 19.07万 - 项目类别:
Immunological Mechanisms Underlying T1dm Pathogenesis
T1dm 发病机制的免疫学机制
- 批准号:
7734282 - 财政年份:
- 资助金额:
$ 19.07万 - 项目类别:
Preclinical studies for measuring beta cell mass in vivo
测量体内β细胞质量的临床前研究
- 批准号:
7734215 - 财政年份:
- 资助金额:
$ 19.07万 - 项目类别:
相似国自然基金
骨髓基质干细胞移植对AD(Alzheimer disease)小鼠海马及额叶神经细胞死亡干预的实验研究
- 批准号:81301089
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
Batten Disease (BD)神经元退化病理机制的研究
- 批准号:30900802
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Exploring the biology of the hepatokine TSK in health and disease.
探索肝因子 TSK 在健康和疾病中的生物学。
- 批准号:
460397 - 财政年份:2022
- 资助金额:
$ 19.07万 - 项目类别:
Operating Grants
New chemical biology approaches to study P2Y2 receptors in health and disease
研究健康和疾病中 P2Y2 受体的新化学生物学方法
- 批准号:
MR/W023768/1 - 财政年份:2022
- 资助金额:
$ 19.07万 - 项目类别:
Research Grant
Cell biology and function of dopamine neuron connectivity in health and disease
健康和疾病中多巴胺神经元连接的细胞生物学和功能
- 批准号:
461714 - 财政年份:2022
- 资助金额:
$ 19.07万 - 项目类别:
Operating Grants
FASEB SRC: The Biology of Calpains in Health and Disease
FASEB SRC:钙蛋白酶在健康和疾病中的生物学
- 批准号:
10463281 - 财政年份:2022
- 资助金额:
$ 19.07万 - 项目类别:
Beyond the Barrier: Alveolar Epithelial Cell Biology in Health and Disease
超越障碍:健康和疾病中的肺泡上皮细胞生物学
- 批准号:
10470030 - 财政年份:2021
- 资助金额:
$ 19.07万 - 项目类别:
Beyond the Barrier: Alveolar Epithelial Cell Biology in Health and Disease
超越障碍:健康和疾病中的肺泡上皮细胞生物学
- 批准号:
10671502 - 财政年份:2021
- 资助金额:
$ 19.07万 - 项目类别:
A Tale of Two Resident Lung Macrophages and Their Biology In Health and Disease
两种常驻肺巨噬细胞的故事及其在健康和疾病中的生物学
- 批准号:
444782 - 财政年份:2021
- 资助金额:
$ 19.07万 - 项目类别:
Operating Grants
Beyond the Barrier: Alveolar Epithelial Cell Biology in Health and Disease
超越障碍:健康和疾病中的肺泡上皮细胞生物学
- 批准号:
10403364 - 财政年份:2021
- 资助金额:
$ 19.07万 - 项目类别:
Fundamental Lysosome Membrane Biology in Health and Disease
健康和疾病中的基础溶酶体膜生物学
- 批准号:
433222 - 财政年份:2020
- 资助金额:
$ 19.07万 - 项目类别:
Operating Grants
The Biology of NBCe1 in Health and Disease
NBCe1 在健康和疾病中的生物学
- 批准号:
10379238 - 财政年份:2019
- 资助金额:
$ 19.07万 - 项目类别: